2023/0131(COD)
Authorisation and supervision of medicinal products for human use and governing rules for the European Medicines Agency
Authorisation and supervision of medicinal products for human use and governing rules for the European Medicines Agency
At a glance
This is 2023/0131(COD). Its recorded status is OLP_FIRST_READING, and 6 linked roll-call votes appear in this research record.
Source and coverage
- Source last checked
- 28/08/2026, 06:01:26
- Record current through
- 24/08/2026
- Institution
- European Union / European Parliament
- Parliamentary term
- Depends on procedure timeline
Coverage limitations: Linked votes are only those for which the ingestion source supplies a reliable procedure relationship. Absence here is not proof that no related parliamentary activity occurred.
Read reporting and briefings ↗
- Procedure
- COD
- Status
- OLP_FIRST_READING
- Primary record
- Legislative Observatory ↗
Linked roll-call votes
Amendments and procedural votes are shown alongside the main/final vote when recorded.
- 2024-04-10main voteUnion procedures for the authorisation and supervision of medicinal products for human use and rules governing the European Medicines Agency
488 for · 67 against · adopted
- 2024-04-10amendment 373Union procedures for the authorisation and supervision of medicinal products for human use and rules governing the European Medicines Agency
129 for · 459 against · rejected
- 2024-04-10amendment 379Union procedures for the authorisation and supervision of medicinal products for human use and rules governing the European Medicines Agency
156 for · 334 against · rejected
- 2024-04-10amendment 378Union procedures for the authorisation and supervision of medicinal products for human use and rules governing the European Medicines Agency
96 for · 450 against · rejected
- 2024-04-10amendment 377Union procedures for the authorisation and supervision of medicinal products for human use and rules governing the European Medicines Agency
73 for · 504 against · rejected
- 2024-04-10amendment 368Union procedures for the authorisation and supervision of medicinal products for human use and rules governing the European Medicines Agency
62 for · 443 against · rejected